Owner Basilea Pharmaceutica AG

Inventors Gaucher, Berangere; Desarbre, Eric; Page, Malcolm G.P.; Roussel, Patrick

Agent Spruson & Ferguson

Pub. Number AU-B-2010246404

Parent 2006322564

Filing date 24 November 2010

Wipo publication date 16 December 2010

Acceptance publication date 28 June 2012

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/43

A61K 31/4427 - containing further heterocyclic ring systems

A61K 31/4436

A61K 31/545 - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

A61K 31/662 - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 31/69 - Boron compounds

A61P 31/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups